Literature DB >> 6980404

Tranexamic acid therapy in ulcerative colitis.

D Hollanders, J M Thomson, P F Schofield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6980404      PMCID： PMC2426294          DOI： 10.1136/pgmj.58.676.87

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  10 in total

1.  Occurrence of C1 inactivator and other proteinase inhibitors in euglobulin fractions and their influence on fibrinolytic activity.

Authors:  C Kluft
Journal:  Haemostasis       Date:  1976

2.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

3.  "Fibrinolytic potential": the response to a 5 minute venous occlusion test.

Authors:  I D Walker; J F Davidson; I Hutton
Journal:  Thromb Res       Date:  1976-05       Impact factor: 3.944

4.  A histochemical study of the fibrinolytic activity. Cornea, conjunctiva, and lacrimal gland.

Authors:  M Pandolfi; T Astrup
Journal:  Arch Ophthalmol       Date:  1967-02

5.  Fibrinolytic activity in the normal and inflamed rectal mucosa.

Authors:  H C Kwaan; A Cocco; A I Mendeloff; T Astrup
Journal:  Scand J Gastroenterol       Date:  1969       Impact factor: 2.423

6.  Anaemia in ulcerative colitis.

Authors:  T P Ormerod
Journal:  Proc R Soc Med       Date:  1968-09

7.  Fibinolysis in colonic disease.

Authors:  C H Swan; J A Williams; W T Cooke
Journal:  Gut       Date:  1970-07       Impact factor: 23.059

8.  The two-period cross-over clinical trial.

Authors:  M Hills; P Armitage
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

9.  Epsilon-aminocaproic acid therapy in ulcerative colitis.

Authors:  N A Mowat; A S Douglas; P W Brunt; J A McIntosh; P C King; K Boddy
Journal:  Am J Dig Dis       Date:  1973-11

10.  Epsilon-aminocaproic acid therapy in ulcerative colitis.

Authors:  R H Salter; A E Read
Journal:  Gut       Date:  1970-07       Impact factor: 23.059
  10 in total
  6 in total

1.  Chronic gastrointestinal haemorrhage controlled by antifibrinolytic agents.

Authors:  J M Willoughby
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

Review 2.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

Review 3.  Tranexamic acid for upper gastrointestinal bleeding.

Authors:  Cathy Bennett; Sarah Louise Klingenberg; Ebbe Langholz; Lise Lotte Gluud
Journal:  Cochrane Database Syst Rev       Date:  2014-11-21

4.  Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces.

Authors:  E de Jong; R J Porte; E A Knot; J H Verheijen; J Dees
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

5.  Systematic evaluation of irinotecan-induced intestinal mucositis based on metabolomics analysis.

Authors:  Qing-Qing Yu; Heng Zhang; Shiyuan Zhao; Dadi Xie; Haibo Zhao; Weidong Chen; Min Pang; Baoqin Han; Pei Jiang
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

Review 6.  Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis.

Authors:  Vipul Jairath; G Y Zou; Claire E Parker; John K MacDonald; Turki AlAmeel; Mohammad Al Beshir; Majid A Almadi; Talal Al-Taweel; Nathan Ss Atkinson; Sujata Biswas; Thomas Chapman; Parambir S Dulai; Mark A Glaire; Daniël R Hoekman; Andreas Koutsoumpas; Elizabeth Minas; Mahmoud H Mosli; Mark Samaan; Reena Khanna; Simon Travis; Geert D'Haens; William J Sandborn; Brian G Feagan
Journal:  Cochrane Database Syst Rev       Date:  2017-09-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.